EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Paraquat Poisoning: Current Advances in Pathophysiology, Diagnostic Biomarkers, and Evidence-Based Management Protocols

Omatighene E.O, Ukoba O, Emuoghenerue O. E, Odonmeta A. B, Enemuwe I. M, Iboyitie I, Obodo O. J

SAP Health and Policy · 2026-07-26 · 5 · 320

DOI: 10.62486/shp2026320 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Paraquat (1,1′-dimethyl-4,4′-bipyridinium dichloride), a widely used herbicide with high human lethality due to its redox cycling, generating reactive oxygen species that induce irreversible multi-organ failure and pulmonary fibrosis. Despite known mechanisms, clinical management remains challenging and mortality exceeds 60%. This systematic review synthesizes global evidence on paraquat toxicity mechanisms, prognostic biomarkers, therapeutic interventions, and public health policies to guide clinical practice and regulatory decision-making. Methods: Following PRISMA guidelines, PubMed, MEDLINE, Embase, Scopus, Web of Science, and WHO IRIS were searched till January 2026. Studies on pathophysiology, diagnostics, treatments, and policy were narratively evaluated. Results: From 1,842 identified studies, 39 met inclusion criteria. Pathophysiologically, cellular uptake via polyamine transporters drives mitochondrial electron leakage, p38 MAPK/NF-κB inflammatory signaling, and TGF-β-mediated interstitial fibrosis. While plasma nomograms and lactate levels reliably predict mortality, targeted therapies show variable success. Randomized controlled trial evidence refutes high-dose immunosuppression benefits, whereas early hemoperfusion (under 4 hours) and restrictive oxygen therapy demonstrate clinical utility. Public health bans in Sri Lanka, South Korea, and Taiwan yielded a 40–50% reduction in pesticide suicides without harming agricultural yields. Conclusion: Prognostic biomarkers accurately identify severe exposures, yet proven clinical treatments remain limited beyond early extracorporeal clearance and restrictive oxygenation. National regulatory restriction stands as the single most effective, evidence-based intervention to prevent paraquat-related fatalities worldwide.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →